Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory framew... by Toon van der Gronde, Carin A Uyl-de Groot, Toine Pieters

Get full text

Reply to comment on Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study by Yi Hsuan Chen, Michiel Kroesen, Mischa S. Hoogeman, Matthijs M. Versteegh, Carin A. Uyl-de Groot, Hedwig M. Blommestein

Get full text

Moving from a registry to a learning health system: A case study of a Dutch prostate cancer registry by Tom Belleman, Jeroen D. H. vanWijngaarden, Malou C. P. Kuppen, Saskia deGroot, Kim J. M. van derVelden, Dianne Bosch, Inge M. vanOort, Carin A. Uyl‐de Groot, Welmoed K. vanDeen

Get full text

The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Ac... by Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C. Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin A. Uyl-de Groot, Jörg Ruof

Get full text

Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy by Elaine Julian, Tom Belleman, Maria João Garcia, Maureen Rutten-van Mölken, Robin Doeswijk, Rosa Giuliani, Bernhard J. Wörmann, Daniel Widmer, Patrick Tilleul, Ruben Casado Arroyo, Valentina Strammiello, Kate Morgan, Marcus Guardian, Michael Ermisch, Renato Bernardini, Fabrizio Gianfrate, Stefano Capri, Carin A. Uyl-de Groot, Mira Pavlovic, Jörg Ruof

Get full text